Journal
CLINICAL CASE REPORTS
Volume 5, Issue 3, Pages 268-269Publisher
WILEY-BLACKWELL
DOI: 10.1002/ccr3.809
Keywords
Apixaban; thrombocytopenia
Categories
Ask authors/readers for more resources
Apixaban is a relatively new drug, and its safety profile is still being established. Thrombocytopenia is an uncommon, but life-threatening side effect with no previous published case repots. Clinicians must be aware of this and exercise caution particularly as some studies hint that it may be used in the management of HIT.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available